Related Experiment Video
Updated: May 5, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Percutaneous balloon aortic valvuloplasty for aortic stenosis in elderly patients at high risk for surgery
Insights
Percutaneous balloon aortic valvuloplasty safely improved aortic valve area and relieved symptoms in high-risk elderly patients with severe calcific aortic stenosis. This minimally invasive procedure offers a viable alternative to surgery for select patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Geriatric Medicine
Background:
- Severe calcific aortic stenosis poses significant risks for elderly patients.
- Surgical valve replacement may be contraindicated due to comorbidities or patient refusal.
- Limited treatment options exist for high-risk patients with symptomatic aortic stenosis.
Purpose of the Study:
- To evaluate the safety and efficacy of percutaneous balloon aortic valvuloplasty (PBAV) in elderly patients with severe calcific aortic stenosis.
- To assess the procedural outcomes, including hemodynamic changes and symptom improvement.
- To determine the feasibility of PBAV as an alternative to surgery in high-risk individuals.
Main Methods:
- Six elderly patients with severe, symptomatic calcific aortic stenosis underwent PBAV.
- Patients were selected due to high surgical risk or refusal of surgery.
- Hemodynamic parameters (aortic valve gradient, valve area) and clinical outcomes were assessed.
Main Results:
- PBAV significantly reduced the mean aortic valve gradient by 32% (p < 0.01).
- The mean aortic valve area significantly increased by 40% (p < 0.001).
- All patients were alive at 2-month follow-up, with significant improvement in dyspnea (1-2 NYHA classes).
- Femoral artery bleeding was the only major complication.
Conclusions:
- PBAV is a safe and effective procedure for improving aortic valve area and alleviating symptoms in elderly patients with severe calcific aortic stenosis at high surgical risk.
- The procedure offers a significant short-term benefit and can be performed with minimal complications.
- PBAV represents a valuable therapeutic option for carefully selected high-risk patients.
Abstract:
Six elderly patients had percutaneous balloon aortic valvuloplasty for severe, symptomatic calcific aortic stenosis because valve replacement surgery was considered too risky in five patients with severe coexisting cardiac or other medical problems and because one patient refused to have surgery. The procedure resulted in a significant reduction in the mean (+/-SD) aortic valve gradient, from 47 +/- 13 to 32 +/- 12 mm Hg (change, -32%, p less than 0.01), and a significant increase in the mean area of the aortic valve, from 0.64 +/- 0.12 to 0.90 +/- 0.17 cm2 (change, +40%, p less than 0.001). Blood loss from the femoral puncture site was the only major procedural complication. At a mean follow-up of 2 months after the procedure, all patients were alive and dyspnea had improved by two New York Heart Association functional classes in four patients and by one functional class in two patients. A significant short-term increase in aortic valve area and alleviation in symptoms can be achieved safely by percutaneous balloon aortic valvuloplasty in elderly patients with severe calcific aortic stenosis who are at high risk for surgical complications.
More Related Videos
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Peripheral Artery Disease III: Interprofessional Care
Aneurysm III: Interprofessional Care